Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Vitalhub Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Vitalhub kazanç ve gelirinin sırasıyla yıllık 65.9% ve 13.5% oranında artması tahmin edilirken, EPS'nin yıllık 56.4% oranında büyümesi bekleniyor.

Anahtar bilgiler

65.9%

Kazanç büyüme oranı

56.4%

EPS büyüme oranı

Healthcare Services kazanç büyümesi	31.1%
Gelir büyüme oranı	13.5%
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	Good
Son güncelleme	01 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Aug 15

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Aug 11

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Feb 06

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Jan 27

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Nov 24

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Nov 16

Is Vitalhub (TSE:VHI) A Risky Investment?

Dec 22

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Apr 28

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Aug 24

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

Jun 29

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

May 18

Is Vitalhub Corp. (CVE:VHI) Potentially Undervalued?

Apr 01

Loss-Making Vitalhub Corp. (CVE:VHI) Set To Breakeven

Feb 16

Does Vitalhub's (CVE:VHI) Share Price Gain of 49% Match Its Business Performance?

Dec 24

An Intrinsic Calculation For Vitalhub Corp. (CVE:VHI) Suggests It's 40% Undervalued

Nov 19

Kazanç ve Gelir Büyüme Tahminleri

TSX:VHI - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	79	N/A	38	N/A	1
12/31/2025	74	12	25	N/A	6
12/31/2024	65	5	12	N/A	6
6/30/2024	58	5	18	18	N/A
3/31/2024	55	6	20	21	N/A
12/31/2023	53	5	20	20	N/A
9/30/2023	50	3	13	14	N/A
6/30/2023	47	0	7	8	N/A
3/31/2023	43	0	4	4	N/A
12/31/2022	40	1	6	6	N/A
9/30/2022	36	1	8	9	N/A
6/30/2022	32	0	5	5	N/A
3/31/2022	29	0	4	4	N/A
12/31/2021	25	-2	0	0	N/A
9/30/2021	23	-2	0	1	N/A
6/30/2021	19	-3	2	3	N/A
3/31/2021	16	-2	1	1	N/A
12/31/2020	14	-2	0	0	N/A
9/30/2020	11	-1	0	0	N/A
6/30/2020	10	-1	-1	-1	N/A
3/31/2020	11	-1	0	0	N/A
12/31/2019	10	-1	0	0	N/A
9/30/2019	10	-1	-1	-1	N/A
6/30/2019	10	-1	-1	-1	N/A
3/31/2019	9	-1	-2	-2	N/A
12/31/2018	9	-1	-2	-2	N/A
9/30/2018	8	-2	-1	-1	N/A
6/30/2018	6	-2	-1	-1	N/A
3/31/2018	4	-2	N/A	-2	N/A
12/31/2017	1	-2	N/A	-1	N/A
9/30/2017	1	-2	N/A	-2	N/A
6/30/2017	1	-2	N/A	-1	N/A
3/31/2017	0	-2	N/A	-1	N/A
12/31/2016	0	-1	N/A	-1	N/A
9/30/2016	0	-2	N/A	-1	N/A
6/30/2016	0	-2	N/A	-1	N/A
3/31/2016	1	-2	N/A	-1	N/A
12/31/2015	1	-2	N/A	-1	N/A
12/31/2014	0	-2	N/A	-1	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: VHI 'nin tahmini kazanç büyümesi (yıllık 65.9% ) tasarruf oranının ( 2.2% ) üzerindedir.

Kazançlar ve Piyasa: VHI şirketinin kazançlarının (yıllık 65.9% ) Canadian pazarından (yıllık 14.6% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: VHI şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: VHI şirketinin gelirinin (yıllık 13.5% ) Canadian pazarından (yıllık 7% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: VHI şirketinin gelirinin (yıllık 13.5% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: VHI 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Vitalhub Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 33%, revenue upgraded

Price target increased by 13% to CA$9.29

Consensus EPS estimates fall by 11%, revenue upgraded

Price target increased by 8.5% to CA$6.92

Price target increased by 11% to CA$6.04

Consensus EPS estimates increase by 44%

Recent updates

Consensus EPS estimates fall by 33%, revenue upgraded

Vitalhub's (TSE:VHI) Performance Is Even Better Than Its Earnings Suggest

Price target increased by 13% to CA$9.29

Vitalhub Corp. (TSE:VHI) Soars 25% But It's A Story Of Risk Vs Reward

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) agreed to acquire MedCurrent Corporation for CAD 33.9 million.

Vitalhub Corp. to Report Q2, 2024 Results on Aug 08, 2024

Consensus EPS estimates fall by 11%, revenue upgraded

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Vitalhub Corp. to Report Q1, 2024 Results on May 09, 2024

Insufficient new directors

Vitalhub Corp. Announces Executive Promotions

Chairman of the Board recently bought CA$1.5m worth of stock

New minor risk - Shareholder dilution

Vitalhub Corp., Annual General Meeting, Jun 27, 2024

Vitalhub Corp. has completed a Follow-on Equity Offering in the amount of CAD 40.254 million.

Vitalhub Corp. has filed a Follow-on Equity Offering in the amount of CAD 35.004 million.

Price target increased by 8.5% to CA$6.92

Full year 2023 earnings: EPS misses analyst expectations

Vitalhub Corp. to Report Q4, 2023 Results on Mar 21, 2024

Price target increased by 11% to CA$6.04

Investor sentiment improves as stock rises 18%

After Leaping 27% Vitalhub Corp. (TSE:VHI) Shares Are Not Flying Under The Radar

Vitalhub Corp. (TSX:VHI) acquired Bookwise Solutions Limited.

If EPS Growth Is Important To You, Vitalhub (TSE:VHI) Presents An Opportunity

Vitalhub Corp.'s (TSE:VHI) P/E Is Still On The Mark Following 40% Share Price Bounce

Shareholders Will Be Pleased With The Quality of Vitalhub's (TSE:VHI) Earnings

Consensus EPS estimates increase by 44%

Investor sentiment improves as stock rises 20%

Price target increased by 8.5% to CA$5.33

Vitalhub Corp. Announces Board Changes

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q3, 2023 Results on Nov 09, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q1, 2023 Results on May 12, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. (TSX:VHI) acquired Coyote Software Corporation for CAD 2.37 million.

Is Vitalhub (TSE:VHI) A Risky Investment?

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Vitalhub Corp. (TSX:VHI) acquired assets to maintain the business of Advanced Digital Innovation.

Vitalhub Corp. to Report Q3, 2022 Results on Nov 10, 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Vitalhub Corp. to Report Q2, 2022 Results on Aug 11, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Vitalhub Corp. to Report Q1, 2022 Results on May 12, 2022

Brokers Are Upgrading Their Views On Vitalhub Corp. (TSE:VHI) With These New Forecasts

Vitalhub Corp., Annual General Meeting, Jun 29, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Director recently bought CA$291k worth of stock

Third quarter 2021 earnings released: CA$0.016 loss per share (vs CA$0.039 loss in 3Q 2020)

Vitalhub Corp.(TSXV:VHI) dropped from S&P/TSX Venture Composite Index

Second quarter 2021 earnings released: CA$0.014 loss per share (vs CA$0.007 profit in 2Q 2020)

Are Investors Undervaluing Vitalhub Corp. (CVE:VHI) By 40%?

Here's Why Shareholders May Want To Be Cautious With Increasing Vitalhub Corp.'s (CVE:VHI) CEO Pay Packet

First quarter 2021 earnings released: CA$0.007 loss per share (vs CA$0.029 loss in 1Q 2020)

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Vitalhub Corp.'s (CVE:VHI) Intrinsic Value Is Potentially 48% Above Its Share Price

President exercised options to buy CA$216k worth of stock.

Price target increased to CA$4.53

Is Vitalhub Corp. (CVE:VHI) Potentially Undervalued?

Full year 2020 earnings released: CA$0.083 loss per share (vs CA$0.035 loss in FY 2019)

Vitalhub Corp. to Report Q4, 2020 Results on Mar 29, 2021

Price target raised to CA$4.38

VitalHub Corp. Announces Multi-Year Licensing Deal with Buckinghamshire Healthcare NHS Trust

Loss-Making Vitalhub Corp. (CVE:VHI) Set To Breakeven